Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body'... Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. The company is also developing single and combination therapies to treat cancers and other life-threatening diseases. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe and Germany. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0019 | -0.213483146067 | 0.89 | 0.979 | 0.85 | 74260 | 0.89369616 | CS |
| 4 | -0.1319 | -12.931372549 | 1.02 | 1.06 | 0.85 | 70744 | 0.9434025 | CS |
| 12 | -0.3869 | -30.3450980392 | 1.275 | 1.54 | 0.85 | 155975 | 1.11638163 | CS |
| 26 | -2.8119 | -75.9972972973 | 3.7 | 4.0413 | 0.85 | 205356 | 1.93611431 | CS |
| 52 | -4.4019 | -83.2117202268 | 5.29 | 8.95 | 0.85 | 301904 | 5.12631194 | CS |
| 156 | -41.2119 | -97.8904988124 | 42.1 | 51 | 0.85 | 907622 | 16.83164437 | CS |
| 260 | -17.8119 | -95.250802139 | 18.7 | 117.4 | 0.85 | 1176924 | 42.0136821 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
